News Release

WEX begins trading on Toronto Stock Exchange

Date: March 10, 2004

Toronto Stock Exchange Trading Symbol: WXI
http://www.wextech.ca
E-mail: wex@wextech.ca

International Wex Technologies Inc. (the "Company" or "Wex") is pleased to announce that the Company's common shares commenced trading today on the Toronto Stock Exchange. Wex has retained the trading symbol "WXI". The company's common shares no longer trade on the TSX Venture Exchange.

Advancing to the Toronto Stock Exchange marks a significant milestone for the company. The senior TSX Exchange will provide access to a larger investment market for our next stage of growth.

International Wex Technologies Inc., a publicly listed neuro-bioscience company (WXI), is focused on the development and commercialization of innovative drug products, primarily for pain management. The Company's lead compound, Tetrodotoxin, is a sodium channel blocker and is the platform for the Company's development of a portfolio of proprietary products in the field of analgesia, drug addiction withdrawal treatment, and local anaesthesia.

For additional information on our products visit us at http://www.wextech.ca or call Gordon Stanley, Corporate Communications at 604-683-8880, or at 1-800-722-7549.

Per: Donna Shum, Corporate Secretary

The Toronto Stock Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this News Release.